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Abstract
Trans women are a key, yet under-researched, population in the HIV epidemic. However, there remains a paucity
of data on the health and wellbeing of trans women at risk of, or living with, HIV in the United Kingdom. This
article provides a narrative review of key empirical research into HIV among trans women. In an effort to explore
individual and social factors in relation to HIV in this population, we outline key tenets of identity process theory
from social psychology and the concept of structural violence from medical anthropology. We focus on pub-
lished studies around the following themes: (1) epidemiological data, (2) syndemic factors (3) barriers to social
support, (4) HIV and gender transitioning, and (5) access to and engagement with health care. We identify lacu-
nae and thus call for United Kingdom-based research in the following areas: (1) the prevalence and incidence of
HIV in trans women, (2) the impact of syndemic factors on HIV risk and acquisition in trans women, (3) the nature
of social support for coping with syndemic factors, (4) the interface of gender transitioning and HIV, and (5) bar-
riers to accessing HIV prevention and care services. There is great scope (and urgency) for research into HIV
among trans women, especially in the United Kingdom, to reduce incidence in this group, to enhance engage-
ment in HIV care across the care continuum, and to improve the health and wellbeing of those living with HIV. A
tentative model for HIV prevention and care is presented in this article.
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Introduction
Almost 40 million people are living with HIV globally.1
Advances in treatment mean that, for those who have
access to HIV medication (known as antiretroviral
therapy [ART]), life expectancy now approaches that
of the general population.2 A key aspect of the manage-
ment of HIV is the HIV treatment cascade (or HIV
care continuum).3 This model of care outlines the
steps that people living with HIV must take from ini-
tially being tested and diagnosed, to being established
on effective ART and achieving viral suppression (hav-
ing a very low level of virus in the body, which drives
the vastly improved clinical outcomes in HIV and re-
duces horizontal transmission of HIV).
The Joint United Nations Program on HIV/AIDS
(UNAIDS) have set a target of 90-90-90; that is, by
2020, for 90% of all people living with HIV to know
their status, for 90% of those diagnosed with HIV to
have sustained ART, and for 90% of those on ART to
have achieved viral suppression.4 However, progress
toward these goals is not equitable, with certain groups
not reaching these targets.5 These key populations are
at higher risk of acquiring HIV, and may also face sig-
niﬁcant challenges in engaging in HIV care. This in turn
may lead to poorer clinical outcomes for the patient and
to increased risk of onward HIV transmission.
Trans women are a key population in the prevention
and management of HIV. However, there remains a
paucity of data on the health and wellbeing of trans
women at risk of, or living with, HIV. Much HIV re-
search focuses on men who have sex with men
(MSM), some of which also include trans women in
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the participant sample.6,7 There has been a tendency in
the literature to conﬂate MSM with trans women, and
often the data are not disaggregated. This tendency not
only obscures differences in epidemiology, access to
health care, and lived experiences between these groups,
but it also fundamentally fails to recognize trans women’s
identities and their speciﬁc health care needs.
This article provides a narrative review of key
empirical research into HIV among trans women.
The aim is not to provide a systematic review of
the literature but rather to outline and discuss over-
arching research themes in the current literature on
HIV among trans women. In an effort to promote
the analysis of both individual and social factors
in relation to HIV in this population, we advocate
the use of identity process theory8 from social psy-
chology and the concept of structural violence9 from
medical anthropology. In this review, we focus on
the following themes: (1) epidemiological data, (2)
syndemic factors, (3) barriers to social support, (4)
HIV and gender transitioning, and (5) access to, and
engagement with, health care. We conclude by describ-
ing a tentative model for preventing HIV and increas-
ing access to HIV care among trans women, and by
presenting recommendations for future research into
HIV among trans women.
Theoretical Frameworks
When considering HIV among trans women, we pro-
pose the use of theoretical perspectives from both psy-
chology and critical medical anthropology, in an effort
to bridge the individual and the structural levels of
analysis. Trans women living with HIV face a multifac-
eted social stigma, as a result of both gender identity
and HIV status.10 It is important to understand how
trans women react to, and cope with, social stigma,
as exposure to stigma can challenge one’s sense of
self and induce negative affect, with adverse outcomes
for both physical and psychological wellbeing.11 A the-
oretical approach that captures multiple levels of anal-
ysis is crucial.
Identity process theory
Identity process theory8 from social psychology can
offer fruitful insights into the ways in which trans
women at risk of, or living with, HIV construct, man-
age and protect identity in the face of social stigma. As
demonstrated in Figure 1, the theory postulates that in-
dividuals construct their identity through engage-
ment in two processes: assimilation-accommodation,
and evaluation. For instance, a trans person diagnosed
with HIV will incorporate their new HIV status into
their existing identity structure and make room for it
FIG. 1. Identity process theory (from Jaspal32).
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within this structure, possibly by rethinking other as-
pects of their identity, such as their ability or desire
to undergo gender reassignment.
The identity processes are in turn guided by vari-
ous motivational principles, namely self-esteem; self-
efﬁcacy; distinctiveness; continuity; and coherence.
When these principles are compromised, for instance,
by changes in one’s social context, identity is said to
be threatened and the individual will deploy strategies
for coping with the ensuing threats. For instance, the
experience of transphobia could plausibly challenge
self-esteem among trans people.12
Some strategies to cope with threat function at a psy-
chological level (e.g., denial), whereas others are enacted
at interpersonal and intergroup levels (e.g., isolation,
deriving social support). Some strategies are proactive
while others are maladaptive. However, all of the strat-
egies aim to maintain or restore high levels of the iden-
tity principles. Thus, by drawing on tenets of identity
process theory, it may be possible to understand partic-
ular patterns of thought and action that could increase
the risk of HIV infection or the risk of poor engage-
ment with HIV care, respectively.
Structural violence
Sociostructural approaches can complement the indi-
vidualized analysis of thought and behavior offered
by identity process theory. Structural violence, as con-
ceptualized by Galtung, refers to violence that extends
beyond the physical domain and that is ‘‘present when
human beings are being inﬂuenced so that their actual
somatic and mental realizations are below their poten-
tial realizations.’’9 Structural violence is not perpetrated
by a subject but is instead ‘‘built into the structure and
shows up as unequal power and consequently unequal
life chances’’ as a result of the uneven distribution of re-
sources and power, and is often not perceived directly.
Structural violence is a central organizing principle
in Critical Medical Anthropology (the branch of med-
ical anthropology that uses critical theory and an ex-
plicit consideration of issues of power to explore
social inequality and ill health), with writers such as
Bourgois13 and Scheper-Hughes14 focusing on how
the macro-level forces of poverty, racism, gender in-
equality, and political violence come to be embodied
by people in the form of ill health.
Paul Farmer in his work in Haiti, Russia, Rwanda,
and the United States has challenged the notion of in-
dividual risk behaviors, showing how increased vul-
nerability to HIV and poor access to HIV care are
predominantly driven by poverty, lack of health infra-
structure, unequal gender relations, discriminatory
practices, and aspects of national and international pol-
icy.15 There is, therefore, a clear precedent for employ-
ing the concept of structural violence when considering
disparities in health, especially in work on HIV and
marginalized groups, such as trans women. The princi-
ple of structural violence sheds light on the social con-
text in which psychological stressors can occur and
adversely impact physical health outcomes among
trans women, a group with decreased social capital,
as outlined in this narrative review.
Methods
L.K. undertook a systematic search of the following elec-
tronic library databases in July–August 2017: PubMed
and PsycINFO. Our aim was to identify original research
articles that examined HIV in trans women, with a focus
on HIV epidemiology, pre-exposure prophylaxis (PrEP),
risk factors for HIV acquisition, access to HIV care, and
HIV clinical outcomes.
The search strategy was developed by L.K. and R.J.
The search was not restricted to a particular time pe-
riod, although we endeavor to include the most recent
data wherever possible. Search terms included: ‘‘trans-
gender’’, ‘‘transsexual’’ (to capture older literature), and
‘‘women’’, all in combination with the terms ‘‘HIV’’ or
‘‘AIDS’’. We applied these search terms to titles in all
databases, and restricted all searches to studies in adults
only. We only included studies published in English.
We did not include gray literature.
We selected studies where at least one of the study
populations was trans women; all study designs were
eligible. In addition, bibliographies of review articles
were crossreferenced and we handsearched available
abstracts from the following conferences: British HIV
Association, Conference for Retroviruses and Oppor-
tunistic Infections, and the International AIDS Society.
Final selection was discussed by all authors until con-
sensus was reached.
In this review, we employ tenets of identity process
theory and structural violence to develop tentative hy-
potheses about HIV risk, and enhancing HIV preven-
tion and care. This is intended to contribute to the
development of a systematic and theoretically informed
research program in this key population.
Epidemiological Data
A 2013meta-analysis of data from 39 studies in 15 coun-
tries, including 11,066 transgender women revealed an
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HIV prevalence of nearly 20% among trans women
globally, with prevalence varying from 18% in low- and
middle-income countries, to 22% in high-income coun-
tries.16 The authors report that, based on these studies,
trans women are 49 times more likely than other adults
to be living with HIV. However, these data must be con-
sidered with caution given that trans women are also less
likely to be engaged in health care, which may mean that
a signiﬁcant number of people in this population are
living with undiagnosed HIV.17
Indeed, a systematic review has indicated a discrep-
ancy between rates of self-reported HIV prevalence
among trans women in the United States, and laboratory-
conﬁrmed HIV infection, suggesting that many trans
women living with HIV may not be aware of their HIV
status and are therefore unable to avail themselves of
life-sustaining ART.18 Furthermore, it is suggested that
trans women are at higher risk of HIV acquisition than
other transgender groups, such as transgender men and
nonbinary transgender people,19 although transgender
MSM are also thought to be at a high risk.20
It is important, however, to note that there are other
intersecting sociodemographic disparities in relation to
HIV vulnerability that may also affect trans women,
such as minority ethnic status and socioeconomic depri-
vation.21 For instance, a United States study of adoles-
cent trans women has found that African American
participants were signiﬁcantly more likely to have ac-
quired HIV compared with their White counterparts.22
We know from existing research that the HIV epidemic
among trans women is also highly patterned by geo-
graphical region.16,23 Therefore, it is not easy to extrap-
olate ﬁndings from global data to the United Kingdom
context.
Until relatively recently, there has been an absence of
data on HIV in trans women in the United Kingdom.
However, in 2017 Public Health England presented
some of the ﬁrst epidemiological data on HIV among
trans women. Drawing on the HIV and AIDS Report-
ing System, which includes data from outpatient HIV
services, Delpech et al.24 of Public Health England
reported that 199 trans individuals accessed HIV care
services in 2016 (0.3% of the total patient cohort), and
that trans patients were twice as likely as other patients
to be diagnosed late (with a CD4 count of <350mm3).
However, there are currently no data on either preva-
lence or incidence of HIV among trans women in the
United Kingdom. This can, in part, be attributed to
the fact that 2011 United Kingdom Census did not
capture the trans and nonbinary (not identifying as
only male or only female, or identifying as both) pop-
ulation size in the United Kingdom, although this may
change in the 2021 Census.
Syndemic Factors and HIV Risk
Trans women face structural violence in the form of a
multitude of social stressors and structural inequalities,
which can plausibly threaten the identity principles of
self-esteem, self-efﬁcacy, continuity, and so on and,
thus, undermine psychological wellbeing.7,25–29
Several studies demonstrate that HIV risk behaviors,
such as condomless anal intercourse, sex work, and
substance use, may sometimes function as a way of
coping (often with unintended negative consequences)
with stigma and other social stressors, which we discuss
below.19,27,30,31 For example, workplace discrimination
may lead to workplace exclusion and potentially to en-
gagement in sex work,32 and social rejection can lead to
substance use as a means of escapism.33 It is easy to see
how such prejudice and discrimination can undermine
the self-esteem and continuity principles of identity.
The co-occurrence and interaction of potentially harm-
ful psychosocial factors and health conditions in a
group is often referred to as a syndemic and is well rec-
ognized in HIV research.34 A syndemic can also be un-
derstood in terms of an event or situation, which
adversely impacts the identity principles of self-esteem,
continuity, self-efﬁcacy, and so on. Understanding
these syndemic factors can enable us to identify the op-
portunities and limitations in relation to both HIV pre-
vention and strategies for engaging trans women living
with HIV throughout the HIV care continuum. This
can also enable us to understand patterns of cognition
and behaviors in a population with an elevated risk of
HIV infection.
Stigma and discrimination
Systemic, institutional and interpersonal discrimina-
tion against trans women can lead to negative psycho-
social and behavioral outcomes.28 The sites of such
discrimination are multifarious and can include inter
alia the family,33 the workplace,28 health care provid-
ers,35 and the criminal justice system,28 with trans
women often facing multiple and intersecting forces
of discrimination and exclusion.
In addition to overt discrimination, such as name-
calling and physical violence, trans women may also
face more subtle forms of discrimination. For instance,
it has been observed that trans gender identity may be
erroneously conﬂated with sexual minority identity
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(including, as discussed earlier, in research), which can
be stigmatizing and distressing.36 There is growing ev-
idence that social stigmatization (on the basis of vari-
ous social categories, such as race, sexuality, gender)
predicts engagement in HIV risk behaviors in trans
women,37 but also in other populations.31 These risk
behaviors may constitute an attempt to deﬂect threats
to self-esteem associated with social stigma.38
Violence
Several empirical studies exhibit a high prevalence of
emotional, physical, and sexual abuse in trans women.
In their longitudinal study of trans women, Nuttbrock
et al.30 note a 29–47% prevalence of psychological and
physical gender-related abuse, while Miller7 found that
trans sex workers were more likely than male sex work-
ers to be physically abused. Several studies exhibit a
high prevalence of intimate partner violence perpetrated
against trans individuals.39,40 Langenderfer-Magruder
et al.39 found that 31.1% of trans people and 20.4% of
cisgender people (people whose gender identity is the
same as the sex they were assigned at birth) in their
study had ever experienced intimate partner violence.
Furthermore, qualitative data demonstrate the sig-
niﬁcant burden of physical violence from the clients
of trans sex workers.23 In their study of trans women
with a history of sex work, Nemoto et al.21 found
that almost 40% of respondents had experienced child-
hood sexual abuse, which is known to constitute a sig-
niﬁcant predictor of increased HIV risk.41,42 In their
study of 60 trans people in Scotland, almost 50% of
whom were trans women, Roch et al.43 found that
80% of their participants had experienced emotionally,
physically, or sexually abusive behavior from an inti-
mate partner. Additionally, data from self-report sur-
veys and needs assessments, hotline call, social service
records, and police reports in the United States suggest
that trans people are at high risk of multiple types of
violence, which begins early in life and continues into
adulthood, and that the risk of sexual violence is partic-
ularly pronounced.44
The experience of abuse can jeopardize the self-
efﬁcacy principle of identity as it deprives the individ-
ual of feelings of control and competence. All of these
forms of abuse are associated with increased HIV risk
and poor engagement with HIV care,31,45 which can
be considered an ineffective coping response to identity
threat. Indeed, Poteat et al.37 have highlighted the effect
of violence and abuse on both HIV risk behaviors and
self-reported HIV prevalence among trans women.
Socioeconomic inequalities
Data from the National Transgender Discrimination
Survey46 suggest that trans individuals are four times
more likely than cisgender individuals to have a house-
hold income of <10,000 US Dollars per year. They are
at elevated risk of homelessness,26 of living in pover-
ty,47 and of experiencing difﬁculties in obtaining and
maintaining employment.35
This socioeconomic hardship among trans people is
also observable in the United Kingdom. For instance, a
2008 survey of lesbian, gay, bisexual, and trans people
in Southern England found that only a quarter of
trans respondents were in full-time employment, and
were three times more likely than non-trans respon-
dents to have an income of <10,000 UK Pounds
(*13,000 US Dollars) a year.48 Data from the more re-
cent Stigma Survey have revealed that a third of trans
people living with HIV in the United Kingdom (the
majority, trans women) report food insecurity and
that a quarter had struggled to keep up with ﬁnancial
commitments, although these rates were not dissimilar
to the overall population living with HIV.29
Socioeconomic inequalities can also challenge iden-
tity processes through the potential threats to self-
efﬁcacy due to the inability to achieve one’s goals and
to self-esteem due to the social stigma that is itself as-
sociated with poverty.49 It is noteworthy that both pov-
erty and homelessness are independently associated
with HIV risk behaviors, such as sex work, substance
misuse, and condomless sex.41,50
Sex work
Socioeconomic inequalities and the need to fund tran-
sition, at least in part, contribute to engagement in sex
work, a risk factor for HIV acquisition. There is a
higher prevalence of history of sex work in trans
women than the general population.51 A United States
meta-analysis suggested that 24–75% of trans women
have engaged in sex work,52 whereas a survey study
of trans women in Lima, Peru revealed a 63.9% preva-
lence of sex work in the participant sample.53
A meta-analysis of 25 studies has reported that trans
women who are sex workers are four times more likely
to be HIV positive than cisgender female sex workers,
although there was no signiﬁcant difference in HIV
prevalence between sex worker trans women and either
non-sex worker trans women or MSM sex workers.54
This is signiﬁcant given that, in a recent report, National
AIDS Trust55 has estimated a higher prevalence of HIV
in trans sex workers than in cisgender sex workers.
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Substance misuse
There is a higher prevalence of substance misuse in
trans women than the general population, which has
been shown to predict engagement in HIV risk behav-
iors in this population.51,56 It has been speculated that
substance misuse may be related to the high prevalence
of sex work in trans women, on the one hand, and the
desire for escapism from pre-existing mental health is-
sues, on the other.7,56 In addition to predicting HIV ac-
quisition, substance misuse is also associated with
increased risk of onward HIV transmission because
substance misuse in people living with HIV is known
to impact adherence to ART, thereby compromising vi-
rological control.57
In recent years, the practice of ‘‘chemsex’’ (drug use
in sexualized settings) has been shown to predict en-
gagement in HIV risk behaviors, such as condomless
sex with multiple partners in a group setting, among
MSM.31 However, there are no data on the prevalence
of ‘‘chemsex’’ in trans women. On the whole, substance
misuse can be conceptualized in terms of a maladaptive
strategy for coping with psychological adversity, such as
identity threat. Yet, the practice itself may also be related
to threats to identity due to the stigma associated with
substance misuse (self-esteem) and to the potential ad-
verse impact for everyday functioning, which can con-
strain one’s competence and control (self-efﬁcacy).
Mental health
Many of the syndemic factors outlined above have an
impact on mental health outcomes. Unresolved iden-
tity threat can result in poor mental health out-
comes, such as depression, anxiety, depersonalization,
and others.58 Furthermore, some coping strategies
can themselves undermine mental health outcomes.
For instance, substance misuse in response to psycho-
logical adversity can increase the risk of psychosis.59
There is evidence that poor mental health is associated
with an increased risk of HIV acquisition and of on-
ward transmission.60,61
In a 2012 survey of mental health among trans peo-
ple in the United Kingdom,26 the majority of respon-
dents reported current or past depression, stress, or
anxiety; 54% were categorized as having major or
mild depression using the Center for Epidemiological
Studies-Depression scale. The prevalence of deliberate
self-harm among trans people is high, with a preva-
lence of suicide attempts of between 32% and 52%
globally, and 63% of those surveyed in the United
Kingdom reported suicidal ideation.62 It is noteworthy
that there is a positive correlation between structural
stigma and suicide attempts.63 However, there is no
empirical research into mental health outcomes and
HIV risk in trans women in the United Kingdom.
Social Support
Social support is a robust empirical predictor of phys-
ical and mental wellbeing64 and for coping effectively
with psychological adversity and identity threat.31
Given the social stigma appended to sexual minorities
and trans people, trans women may experience a sense
of disconnection from social ingroups and, thus, de-
creased access to social support. Forbes et al.19 have
found that social support can enhance resilience in
trans women. Consequently, a lack of social support
can constrain trans women’s capacity to cope with ad-
versity and negatively impact mental and physical
health.65,66
Westbrook and Schilt67 have shown that trans people
may have limited access to potentially helpful social
spaces, such as HIV support groups, in part because
of the stigma surrounding trans gender identity.
HIV-related stigma can adversely impact access to so-
cial support among trans women living with HIV as a
result of the desire to avoid sharing one’s HIV status
to protect oneself from stigma and rejection.68
The ability to draw upon social support to cope with
an HIV diagnosis depends on the individual’s will-
ingness to share their HIV status with others. In
their national study of adults attending for HIV care
at a United Kingdom clinic, Daskalopoulou et al.69
found that participants who had not told anyone
about their HIV status were more likely to report low
social support, symptoms of depression and anxiety,
and nonadherence to ART, and to have uncontrolled
HIV. Yet, sharing one’s HIV status is possible only if
an individual has a trusted other, which, given the
low levels of social capital among trans women out-
lined above, may preclude this process.
While sharing one’s HIV status with others consti-
tutes a positive coping strategy and can provide a mul-
titude of social and psychological beneﬁts to people
living with HIV, there are also associated risks. Quali-
tative research has revealed that trans women living
with HIV may feel that an HIV diagnosis could re-
inforce stigmatizing stereotypes of trans women as
‘‘dirty’’, preventing them from sharing their diagnosis
with others.56 Furthermore, the association between
an HIV diagnosis (and others knowing about this)
and gender-based violence is well recognized among
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cisgender women living with HIV.70 UNAIDS45 has
identiﬁed the high risk of exposure to sexual violence
among trans women. There is currently no empirical
research into the role, or even availability, of social sup-
port in preventing HIV among trans women in the
United Kingdom.
HIV and Gender Transitioning
Gender transitioning is the process whereby trans
people undergo change to live in a way that is congru-
ent with their gender identity. Transitioning can occur
within a number of spheres, which may be independent
of one other—for example, social, legal, and medical. It
can potentially challenge the continuity principle of
identity in view of the inevitable changes in interper-
sonal relations that occur during this process. Con-
versely, barriers to transitioning can be challenging
for continuity because of the consequential discrepancy
between individuals’ desired and actual identities.71
Medical transitioning involves physical changes to
the body through hormone therapy and/or surgical in-
tervention. Some ART regimens are known to interact
with estrogen (one of the main hormones administered
for medical transition), thereby reducing exposure to
estrogen.72 This can adversely impact medical transi-
tioning and induce concerns in trans patients living
with HIV regarding the quality of their medical transi-
tion. Indeed, a survey of 87 trans women living with
HIV in the United States reports high levels of ART
nonadherence as a result of concerns about the poten-
tial of drug interactions to undermine the transition
process,73 which has previously been reported by
other researchers.56,63
This is particularly concerning given that Wilson
et al.74 found that nonuse of transition-related medical
care among trans women (in particular, hormone ther-
apy and breast augmentation) was associated with sub-
stance misuse, alcohol misuse, and suicidal ideation. As
indicated above, all of these practices are associated
with increased risk of HIV acquisition/transmission.
It is therefore necessary to understand perceptions of,
and attitudes toward, both ART and hormone replace-
ment therapy among trans women living with HIV so
as not to compromise either their HIV treatment or
their medical transition.
Body image concerns and eating disorders are prev-
alent in trans women.25,75 Weight gain has been
reported with many commonly prescribed antiretrovi-
ral medications.76 Although there has been no empiri-
cal research into the impact of ART-related body shape
changes on trans women living with HIV, ART-related
lipodystrophy (the abnormal distribution of fat that
was associated with older antiretroviral agents) has
been shown to cause distress and loss of self-efﬁcacy
in cisgender men living with HIV in the United King-
dom.77 It is important to explore body image concerns
in trans women living with HIV, as this may plausibly
impact perceptions of HIV treatment and/or gender
transitioning in this population.
There is a dearth of research into the relationship be-
tween gender conﬁrmation surgery and HIV risk. In
the case of trans women, gender conﬁrmation surgery
may involve the surgical construction of a ‘‘neovagina’’
through a variety of procedures, including penile skin
inversion, partial bowel transplant, and skin grafting.78
It has been hypothesized that trans women with neova-
ginas may be at an increased risk of HIV acquisition
due to changes in the immunological microenviron-
ment as a result of surgery.79 Conversely, Poteat
et al.23 argue that there are some protective factors as-
sociated with the neovagina, such as the hardening of
tissue after healing. It is likely that other factors mod-
erate the link between gender conﬁrmation surgery
and HIV risk, such as the method and quality of surgi-
cal construction, the nature and frequency of sexual in-
tercourse, and the use of lubricants. However, it is clear
from the existing literature that this remains an under-
researched area.
Access to Health Care
Trans women experience signiﬁcant barriers to access-
ing health care, including HIV care.80–82 This can be at-
tributed partly to the lack of targeted services, as well as
to gender discrimination and transphobic microaggres-
sions perpetrated by health care professionals.56,74
Nadal et al.27 deﬁne microaggressions as subtly anta-
gonistic behaviors, such as misgendering (using incor-
rect gender pronouns), asking unnecessary intimate
questions about gender and sexuality, and wilfully ig-
noring the existence of transphobia. They also note
the adverse impact that microaggressions can have
for wellbeing among trans people. It is easy to see
how this can adversely affect self-esteem, and how dis-
engagement from health care may in turn constitute an
attempt to protect self-esteem.
The perception of poor-quality interactions with
health care professionals constitutes a signiﬁcant bar-
rier to accessing health care among trans patients.83
Trans patients may feel that they obtain low-quality
health care due to a perceived lack of knowledge of
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trans people’s needs among health care practitioners.
This perception may be grounded in reality—only 13%
of United Kingdom nurses surveyed felt that they were
sufﬁciently equipped to treat transgender patients.55
Stigma can adversely impact engagement with and
retention in health care.84 An HIV diagnosis can add a
further stigmatized identity element to trans gender
identity, which can compound oppression and adversely
affect the quality of health care.56,83 Indeed, the 2016
United Kingdom Stigma Survey found a high prevalence
of concerns in trans people about being treated differ-
ently by health care providers in a wide range of settings
(the overwhelming majority, trans women) with sub-
stantial numbers avoiding health care as a result.29
Furthermore, lack of family and social support is also
associated with disengaging from HIV care among
trans women.85 Poor engagement with health care ser-
vices can impact the HIV continuum at all points, from
HIV testing to uptake and continued adherence to
ART. This in turn may contribute to late diagnosis, in-
creased morbidity and mortality, and an increased risk
of onward HIV transmission.
Access to health care may be further compromised by
low levels of HIV-related health literacy. Despite the
well-documented efﬁcacy of PrEP and post-exposure
prophylaxis (PEP), two biomedical HIV prevention ap-
proaches,86,87 knowledge of these approaches among
trans women in the United Kingdom is reported to be
low. In their survey of 44 trans people testing for HIV
at a sex-on-premises venue in London, Wolton et al.88
found that over 70% had no knowledge of PrEP or
PEP, and that many expressed concerns about potential
drug interactions with hormones. More generally, there
is a paucity of data on the acceptability of PrEP and PEP
among trans women, which means that potential barri-
ers to uptake of these highly efﬁcacious prevention
methods are poorly understood in a group known to
be at high risk of HIV acquisition.89
Moreover, waiting lists for Gender Identity Clinics,
the initial point of contact within health services for
trans people wishing to transition medically, are grow-
ing.90 This can have important implications for the
physical and psychological wellbeing of trans people,
many of whom face structural violence, and some of
whom are living with HIV. For example, Nambiar
et al.91 report that nearly 40% of trans people attending
their specialist sexual health service in the United King-
dom self-medicate with hormones if unable to access
hormones in clinical settings and may be unaware of
potential drug interactions. However, it is noteworthy
that the majority of those reporting nonprescribed
hormone replacement therapy in that study were trans
men, so there is a need for empirical insight into trans
women.
Studies suggest that trans women living with HIV
are less likely to adhere to ART and less likely to
achieve viral suppression than cisgender patients living
with HIV.92 A recent case note review of 32 trans
women attending a trans sexual health clinic for HIV
care found that nearly a third had taken a break from
their ART, and that one ﬁfth had a detectable HIV
viral load compared with 4% among cisgender patients
attending the general HIV service.88 It is important to
gain an understanding of engagement with HIV care
and HIV clinical outcomes in trans women in a larger
sample of trans patients in the United Kingdom. It is
possible that identity concerns play a signiﬁcant role
in engagement with health care.
Discussion
Trans women are a key group in the HIV epidemic.
This is a group at high risk of HIV acquisition, and
those living with HIV are at risk of poorer clinical out-
comes as a result of the challenges associated with
accessing and engaging with HIV care at all points of
the care continuum. In this review, we have discussed
both the individual- and macro-level factors that may
contribute to these increased risks, highlighting the
role of identity process theory and structural violence
in providing a theoretical framework that can enhance
our understanding of HIV in trans women.
A model for HIV prevention and care
among trans women
In previous research into HIV risk in other popula-
tions,31 it has been argued that social stressors (one
form of structural violence) can threaten identity and
give rise to various strategies for coping. This in turn
can put the individual at risk of HIV and poor sexual
health outcomes. Drawing upon our ﬁndings from
this narrative review, we offer a modiﬁed version of
this model as applied to trans women and HIV (Fig. 2).
We hypothesize that both structural violence (e.g.,
transphobia, sexism, racism) and direct violence (e.g.,
physical, sexual, and emotional abuse) can threaten
identity, but that this is likely to be mediated by the
availability of social support and access to afﬁrmative
Gender Identity services, which can offer critical sup-
port in the face of gender-related adversity. As pre-
dicted by identity process theory, identity threat can
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result in negative affective states (e.g., guilt, shame, and
anxiety), which are aversive for psychological wellbeing.
The individual will in turn attempt to cope—either
adaptively or maladaptively. Possible maladaptive
strategies include condomless sex, substance misuse,
and disengagement from care, all of which can increase
the risk of HIV and decrease engagement with care
among those living with HIV. Adaptive coping strategies
include the derivation of social support and engagement
with care, which in turn can prevent HIV acquisition
and increase engagement with care among those liv-
ing with HIV.
It is likely that the availability of social support and
practitioner engagement mediate the relationship be-
tween threat and type of coping response. More specif-
ically, practitioner awareness of identity process theory,
structural violence, and therapeutic models can support
trans women—both those at risk of, and living with,
HIV—in adopting adaptive coping strategies and mov-
ing away from those which may be maladaptive.
We suggest that this model be tested in this popula-
tion through empirical research. We argue that inter-
ventions for preventing HIV and promoting better
outcomes throughout the HIV care continuum, may
beneﬁt from the multilevel tenets of this model. More
speciﬁcally, it is likely that addressing the multiple
and intersecting oppressive forces of transphobia, sex-
ism, and racism (including within health care settings),
the provision of greater social support, and a more gen-
der identity afﬁrming approach from practitioners will
greatly enhance outcomes in this population. By recog-
nizing the distinctiveness of trans identities and by un-
derstanding what factors may promote more positive
identities (characterized by a supportive social net-
work), we will be better positioned to support the
health and wellbeing of this key population in the
HIV epidemic.
Limitations and next steps
A limitation of this review is that it is a narrative, rather
than systematic, review. However, in view of the pau-
city of literature pertaining to trans women and HIV,
and the comprehensive nature of our review, we believe
that it constitutes an important contribution to current
knowledge. We present a theoretical framework, within
which to conceptualize trans women’s risk of HIV, and
also their engagement with HIV care. It is important to
highlight that this is based on our review of current lit-
erature and existing theory, and that this model needs
to be tested in empirical research. Finally, it is clear that
the majority of studies presented in this review were
conducted in North America. Findings from these
studies may not be applicable in other settings where
local HIV epidemiology, the sociodemographic proﬁle
FIG. 2. A model for understanding the micro- and macro-level HIV risk factors in trans women (adapted from
Jaspal32).
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of trans women, the legal context, and access to health
care may differ. However, there are important and
transferable insights to be gained from these studies.
To our knowledge, this is one of the ﬁrst major re-
views of HIV and trans women, which seeks to explic-
itly incorporate a theoretical framework. Furthermore,
in drawing upon identity process theory and the con-
cept of structural violence, we aim to bridge micro-
and macro-level processes that may shape HIV risk
and impact the HIV care continuum among trans
women. A further strength of the review is the inclu-
sion of quantitative (including those using an experi-
mental design) and qualitative studies.
Crucially, this review has enabled us to identify key
lacunae in the literature on HIV and trans women in
the United Kingdom. First and foremost, it is not ap-
propriate to assume that the needs of trans women
are identical to other gender identity groups given the
speciﬁc oppressive forces that trans women encounter,
even within health care settings. Furthermore, it is im-
portant to acknowledge that in conﬂating trans women
with MSM, researchers are eliding a fundamental as-
pect of trans women’s identities.
Globally there are notable lacunae in data including:
long-term safety and risk of comorbidities among trans
women taking hormone therapy; the impact of gender
conﬁrmation surgery on HIV infection risk; the role of
related syndemics, such as substance misuse (especially
chemsex), poor mental health, and violence, in HIV ac-
quisition risk and engagement in HIV care; and qualita-
tive research that sheds light on the lived experience of
trans women at risk of, or diagnosed with, HIV. More-
over, existing work often fails to acknowledge the more
positive aspects of trans women’s lives, and we would
therefore encourage researchers to engage with subjects,
such as resilience and sexual pleasure, to avoid perpetuat-
ing a stereotype of trans women as victims.
The literature on trans women and HIV is nascent
in the United Kingdom. This review has highlighted
the geographical variation of the HIV epidemic among
trans women globally. It is therefore critically important
that we generate national surveillance data on the ep-
idemiology and care of trans women living with HIV.
Public Health England’s recently published data on
HIV among trans people in the United Kingdom24
is therefore an important ﬁrst step and we welcome
their future work utilizing nonbinary gender categories
in their surveillance data collection. We also look for-
ward to results from Positive Voices, a survey of the ex-
periences and health care needs of people attending for
HIV care in England, which includes a sample of trans
women.93
We identiﬁed no research into the effectiveness of HIV
prevention programs for trans women in the United
Kingdom, although there has been a critical review
study of interventions in the United States.94 Barriers
to participating in research among trans women in-
clude concerns about stigma, fears about drug interac-
tions (with regard to clinical trials), and previous poor
experiences of engaging with health care profession-
als.95 However, future research should aim to address
these barriers and acknowledge the needs of this com-
munity that can improve HIV prevention efforts, and
HIV outcomes.
Conclusion
In this review, we have drawn upon studies primarily
conducted outside of the United Kingdom due to the
paucity of United Kingdom-speciﬁc data. Much of this
work is valuable in enhancing our understanding of
HIV risk in trans women, but there is a need for United
Kingdom data—both quantitative and qualitative. We
believe that there is great scope (and urgency) for re-
search into HIV among trans women, especially in the
United Kingdom, to carve out evidence-based pathways
for reducing incidence in this group, for addressing
inequities in the HIV care continuum, and for improv-
ing the health and wellbeing of those living with HIV.
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